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Abstract The biofilms formed by opportunistic yeasts serve
as a persistent reservoir of infection and impair the treatment
of fungal diseases. The aim of this study was to evaluate
photodynamic inactivation (PDI) of biofilms formed by Can-
dida spp. and the emerging pathogens Trichosporon mucoides
and Kodamaea ohmeri by a cationic nanoemulsion of zinc
2,9,16,23-tetrakis(phenylthio)-29H,31H-phthalocyanine
(ZnPc). Biofilms formed by yeasts after 48 h in the bottom of
96-well microtiter plates were treated with the photosensitizer
(ZnPc) and a GaAlAs laser (26.3 J cm–2). The biofilm cells
were scraped off the well wall, homogenized, and seeded onto
Sabouraud dextrose agar plates that were then incubated at
37°C for 48 h. Efficient PDI of biofilms was verified by
counting colony-forming units (CFU/ml), and the data were
submitted to analysis of variance and the Tukey test (p<0.05).
All biofilms studied were susceptible to PDI with statistically
significant differences. The strains of Candida genus were
more resistant to PDI than emerging pathogens T. mucoides
andK. ohmeri. A mean reduction of 0.45 log was achieved for
Candida spp. biofilms, and a reduction of 0.85 and 0.84, were
achieved for biofilms formed by T. mucoides and K. ohmeri,
respectively. Therefore, PDI by treatment with nanostructured
formulations cationic zinc 2,9,16,23- tetrakis (phenylthio)-
29H, 31H- phthalocyanine (ZnPc) and a laser reduced the
number of cells in the biofilms formed by strains ofC. albicans
and non-Candida albicans as well the emerging pathogens T.
mucoides and K. ohmeri.
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Introduction
Candida albicans is the most common species isolated from
the oral cavity, followed by C. glabrata, C. tropicalis, C.
parapsilosis, and C. krusei. However, other non-Candida
albicans emerging species have arisen, such as C. dublin-
iensis, C. lusitaniae, C. rugosa, C. norvegensis, C. kefy, C.
lypolitica, and C. guilliermondii, due to a growing population
of immunosuppressed patients and the use of broad-spectrum
antibiotics [1, 2]. Yeasts from the Candida genus are respon-
sible for the majority of fungal infections in immunocompro-
mised patients owing to the use of immunosuppressive drugs
and characteristics of the individual, such as advanced age and
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systemic diseases. The oral cavity is the most common site of
infection [3, 4].
The treatment of diseases caused by yeast in the Candida
genus in immunocompromised patients is problematic
because the yeasts have become increasingly resistant
to antifungal agents. Schelenz et al. [2] isolated 266 oral
yeasts of the Candida genus from patients with hemato-
logical malignancies and head and neck solid tumors and
found that 28.2% of the isolates were resistant and
23.7% were susceptible dose dependant (SDD) to fluco-
nazole, itraconazole, ketoconazole, voriconazole, and
caspofungin. The majority of these resistant strains were
C. glabrata and C. krusei. Besides these species, C.
lusitaniae can also develop secondary resistance to
amphotericin B, and another emerging pathogen, C. dub-
liniensis, acquires secondary resistance to fluconazole
more quickly than C. albicans [5, 6].
Candida species are able to organize into complex com-
munities known as biofilms, which are composed of blasto-
conidia, pseudohyphae, and hyphae, and are embedded in a
matrix of extracellular polymeric substances (EPS) that form
channels and pores [7]. It is currently estimated that approx-
imately 65% of all treated infections are associated with
microbial biofilm formation on the surfaces of tissues,
organs or medical devices [8]. Biofilm formation is the
biggest obstacle to effective treatment of infections caused
by Candida, because these structures exhibit different phe-
notypic characteristics than their planktonic counterparts,
such as reduced susceptibility to antifungal agents and pro-
tection from the immune system [9].
In addition, other yeast genera have been identified from
immunocompromised hosts with poor prognoses. For ex-
ample, Trichosporon is an emerging yeast pathogen capable
of causing invasive disease in patients with hematological
malignancies [10, 11]. T. asahii is the species most often
implicated in deep-seated infections, like trichosporonosis,
in immunocompromised and HIV-positive patients, fol-
lowed by T. mucoides, T. inkin, T. asteroids, T. cutaneum,
and T. ovoides [11, 12]. The best therapy for invasive
trichosporonosis is undefined, and little data is available
on effective treatments. In the literature, there have been
reports of reduced susceptibility to amphotericin B and
antifungal activity of fluconazole; however, in vitro obser-
vations of fluconazole action do not have a strong correla-
tion with good clinical outcomes [10, 13]. Furthermore,
Trichosporon is capable of forming complex biofilms sim-
ilar to Candida with intrinsic resistance to the antifungals
amphotericin B, caspofungin, fluconazole, and voriconazole
[14].
Kodamaea ohmeri, an ascosporogenous yeast and a tele-
omorph of Candida guilliermondii var. membranaefaciens,
is an extremely uncommon human pathogenic yeast [15]. K.
ohmeri is an environmental strain commonly used in the
food industry for the fermentation of pickles, rinds, and fruit
[16]. It causes invasive opportunistic infections in immu-
nocompromised hosts and is often associated with the
presence of implanted devices. It also has developed
resistance to azoles and a reduced susceptibility to cas-
pofungin [16–19]. K. ohmeri has already been isolated
from HIV-positive patients with pseudomembranous oral
candidiasis and from diabetic and hemodialyzed users of
dental prostheses [20, 21].
In the future, the biggest challenge will be to choose a
suitable antifungal agent that can be used to treat diseases
caused by emerging pathogens. Photodynamic inactivation
(PDI) has been used to successfully inactivate yeasts that are
either sensitive or resistant to antifungal agents [22, 23]. PDI
consists of irradiating a photosensitive, non-toxic agent with
a light source of suitable wavelength in the presence of
oxygen to produce reactive oxygen species (ROS) or free
radicals that damage cells [24, 25]. The photosensitive
agents used include hematoporphyrin derivatives, pheno-
thiazines (toluidine blue and methylene blue), cyanines,
phytotherapeutic agents, xanthenes, and phthalocyanines
[26].
Phthalocyanine photosensitizers seem to be a promising
alternative for PDI application in dentistry. They are char-
acterized by far-red wavelength absorption (> 670 nm), long
triplet lifetime (∼1 ms), high quantum yields of singlet
oxygens (> 0.2), and low dark toxicity [28–30]. The main
advantage in the use of phthalocyanine as photosensitizer is
the fact that this family of dyes could act by the two classical
PDI mechanisms of radical production (type I) or singlet
oxygen (type II) [31]. These photosensitizers are more ef-
fective in ROS generation after light activation and have less
capacity to stain dental structures compared to the traditional
phenothiazine molecules [27].
Phthalocyanines can be modified to have a positive or
negative charge. The charge of the photosensitizer is an
important factor in determining its effective photodynamic
action and whether cells uptake it. Gram-negative bacteria
and fungi are resistant to anionic and neutral phthalocya-
nines [28, 29]. In this study, the photodynamic action of a
nanostructured formulation cationic zinc 2,9,16,23-tetrakis
(phenylthio)-29H,31H-phthalocyanine (ZnPc) was used for
inactivating biofilms of different Candida species, T.
mucoides, and K. ohmeri.
Materials and methods
Yeasts strains
The study was approved by the Ethics Committee of the
School of Dentistry of São José dos Campos, UNESP (proto-
col 051/2009-PH/CEP).
1206 Lasers Med Sci (2012) 27:1205–1212
Thirty-nine yeast strains isolated from the oral cavity of
HIV-positive patients were used, including ten C. albicans,
seven C. glabrata, six C. tropicalis, four C. dubliniensis,
four C. parapsilosis, two C. norvegensis, two C. krusei, one
C. lusitaniae, one C. guilliermondii, one T. mucoides, and
one K. ohmeri. These strains were obtained from the Labora-
tory ofMicrobiology and Immunology, School of Dentistry of
São José dos Campos, UNESP.
Photosensitizer and light source
ZnPc (Sigma-Aldrich Chemical Co., Milwaukee, WI, USA)
was used for sensitization of the yeast strains. This photo-
sensitizer was sterilized by filtration through 0.22-μm pore
membranes (MFS, Dublin, CA, USA).
ZnPc was entrapped into cationic nanoemulsions (NE) to
controlled drug release and optimal biological target. NE are
advanced drug-delivery systems obtained from pharmaceu-
tical nanotechnology applied on topical and transdermical
administration of active compounds. In this work, we car-
ried out a highly stable NE that was obtained from sponta-
neous emulsification as described by Primo et al. [32] by a
direct mixture of organic phase containing the lecithin soy/
ZnPc/oily and aqueous phase containing the biopolymer/
emulsifier to final drug concentration at 0.25 mg/ml. The
nanomaterial was prepared under aseptic conditions being
able to biological assays. Dynamic light-scattering analyzes
were carried out and showed a medium particle size of 194.3
(±5.7) nm, polydispersity index (PdI) of 0.19 (±0.04) and
zeta potential at +72.1 (±5.9) mV. The particle size, PdI and
zeta potential were monitored until 90 days showed appropri-
ated physical-chemistry stability according to the required to
development of drug nanocarriers.
The light source used was a gallium-aluminum-arsenide
(GaAlAs) laser (Easy Laser, Clean Line, Taubaté, SP, Brazil)
with a wavelength of 660 nm, output power of 0.035 W, and
illuminated area of 0.38 cm2. A fluence of 26.3 J cm–2 (energy
of 10 J and time of 285 s) and a fluence rate of 92 mWcm–2
were used.
Photodynamic inactivation of biofilms formed by yeasts
The methodology described by Jin et al. [33] was used for
biofilm growth, with some modifications. Cultures of yeasts
that were grown on Sabouraud dextrose (Himedia, Mumbai,
Maharashtra, India) agar at 37°C for 18 h were harvested in
yeast nitrogen base (YNB, Himedia) supplemented with
100 mM glucose (Vetec, Duque de Caxias, RJ, Brazil). After
an 18-h incubation at 37°C, the yeasts were centrifuged at
358×g for 10 min, washed twice with PBS, resuspended in
YNB supplemented with 100 mM glucose, and adjusted to
an optical density of 0.38 at 530 nm (107 cells/ml) using a
spectrophotometer (B582, Micronal, São Paulo, SP, Brazil).
A 100-μl aliquot of each suspension was pipetted into
each well of a 96-well flat-bottom microtiter plate (Costar
Corning, New York, NY, USA). The plate was incubated for
1.5 h at 37°C in a shaker at 75 rpm (Quimis, Diadema, SP,
Brazil) for the initial adhesion phase. After this period,
the wells were washed with 100 μl of PBS to remove
loosely adhered cells. A 250-μl aliquot of YNB with
100 mM glucose was then pipetted into each of the
washed wells, and the plates were incubated at 37°C
in a shaker at 75 rpm for 48 h. The broth was changed
every 24 h. The plates containing biofilms formed by
yeasts were then washed with 250 μl of PBS to remove
loosely adhered cells.
The biofilm formed by each strain was immersed in
250 μl of a solution of ZnPc for 5 min (pre-irradiation time)
in an orbital shaker (Solab, Piracicaba, SP, Brazil). Subse-
quently, the suspended plates were irradiated according to
the protocol described (P+L+, n03). The effects of exposure
to phtalocyanine photosensitizer alone (P+L-, n03), the
light source alone (P-L+, n03), or to neither (P-L-, n03);
treated with PBS in the absence of light were evaluated as
well.
After the treatments, the cells in the biofilm were scraped
off the well wall using a sterile toothpick and were trans-
ferred to Falcon tubes containing 10 ml of PBS. To disrupt
the biofilms, the contents of the tubes were homogenized for
30 s using an ultrasonic homogenizer (Sonoplus HD 2200;
Bandelin Electronic, Berlim, Brandenburg, Germany) with
an output power of 50 W. The solutions in the Falcon tubes
were considered to be a dilution factor of 10–1. Serial
dilutions were then made using each original 10–1 dilution,
and aliquots of 0.1 ml were seeded onto Sabouraud dextrose
agar plates that were then incubated at 37°C for 48 h. After
the incubation period, the number of colony-forming units
(CFU/ml) on each plate was determined.
Irradiation of the biofilms was performed under aseptic
conditions in a laminar flow hood in the dark. During
irradiation, the plates were covered with a black matte
screen with an opening the same size as the wells to prevent
the spread of light to neighboring wells.
Statistical analysis
For statistical analysis, the species were classified as C.
albicans, non-albicans Candida species, and non-Candida
species. The data for CFU/ml were converted to logarith-
mic form and subjected to analysis of variance and the
Tukey test. A p value<0.05 was considered statistically
significant.
The percentage of CFU/ml reduction for C. albicans,
non-albicans Candida species, and non-Candida species
was calculated, considering the groups P+L-, P-L+,
and P+L+ in relation to the control group (P-L-).
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Results
Table 1 shows the values of CFU/ml obtained in the P-L-, P
+L-, P-L+, and P+L+ groups for the biofilms of each species
studied. CFU/ml values for all species were reduced by PDI
(P+L+) compared to the control group (P-L-). The greatest
reductions were observed for T. mucoides (0.85 log) and K.
ohmeri (0.84 log), followed by C. tropicalis (0.64 log), C.
guilliermondii (0.59 log), C. dubliniensis (0.53 log), C.
parapsilosis (0.51 log), C. lusitaniae (0.38 log), C. norve-
gensis (0.37 log), C. krusei (0,36 log), C. albicans (0.35
log), and C. glabrata (0.33 log).
Figures 1, 2, and 3 show the results obtained by a com-
parison among P-L-, P+L-, P-L+, and P+L+ groups for the
strains of C. albicans, non-albicans Candida species, and
non-Candida species. The treatments with photosensitizer
(P+L-) and laser (P-L+) alone demonstrated cytotoxic
effects, gauged by a reduction of CFU/ml, for all biofilms
studied, but statistically significant differences were ob-
served for C. albicans and non-Candida species in the P
+L- group, and for all species in the P-L+ group, compared
with the control group (P-L-). PDI (P+L+) resulted in sta-
tistically significant differences for all species in relation to
the control group (P-L-).
The percentages of CFU/ml reduction for the P+L-, P-L+,
P+L+ groups compared to the control group (P-L-) are
shown in Fig. 4.
Discussion
The first step in the formation of yeast biofilms is the adher-
ence of cells to a host surface, like epithelial, endothelial or
indwellingmedical devices, and development of blastoconidia
into distinct microcolonies, leading to the formation of a
biofilm embedded in a matrix of EPS. Once established,
yeasts biofilms serve as persistent reservoirs of infection
and, in addition, confer greater resistance to antifungal agents
and protection against host immune defenses [7, 14, 34, 35].
In this study, we evaluated the effects of photodynamic inac-
tivation mediated by cationic nanoemulsion of zinc 2,9,16,23-
tetrakis(phenylthio)-29H,31H-phthalocyanine on biofilms
formed by Candida spp., T. mucoides, and K. ohmeri. The
effects of the isolated photosensitizer (P+L-) and light source
(P-L+) were evaluated as well.
Exposure to the photosensitizer in the dark (P+L-) had a
cytotoxic effect on the species studied, with significant
differences between the biofilms made by C. albicans and
non-Candida species. The reduction relative to the control
group was lower (< 0.18 log) than that found by Mantareva et
al. [28]. This group treated biofilms with tetrakis-(3-methyl-
pyridyloxy)- and tetrakis-(4-sulfophenoxy)-phthalocyanine
zinc(II) at a concentration of 1.5 and 6 μM in the dark and
observed cytotoxic effects with a reduction of less than 0.50
log for the microorganisms C. albicans, Staphylococcus
aureus, and Escherichia coli.
Treatment with the laser alone (P-L+) in the present study
also showed an antifungal effect against all biofilms with
significant reduction for the species of C. albicans, non-
Table 1 Mean CFU/ml (log)
and standard deviations for the
biofilms of C. albicans,
non-albicans Candida species,
and non-Candida species
submitted to different
experimental treatments (n03):
PBS as control (P-L-);
photosensitizer (P+L-); laser and
PBS (P-L+); and laser and
photosensitizer (P+L+)
Yeasts Strains P-L- P+L- P-L+ P+L+
C. albicans C. albicans (10) 7.30±0.07 7.18±0.08 7.13±0.07 6.95±0.07
Non-albicans
Candida species
C. glabrata (7) 7.68±0.12 7.50±0.21 7.54±0.19 7.35±0.24
C. tropicalis (6) 7.35±0.07 7.26±0.08 7.08±0.03 6.71±0.14
C. dubliniensis (4) 7.42±0.26 7.33±0.21 7.09±0.22 6.89±0.23
C. parapsilosis (4) 7.46±0.04 7.32±0.08 7.19±0.09 6.95±0.06
C. norvegensis (2) 7.32±0.08 7.23±0.11 7.15±0.09 6.95±0.08
C. krusei (2) 7.39±0.04 7.30±0.02 7.14±0.01 7.03±0.01
C. lusitaniae (1) 7.34±0.08 7.29±0.01 7.27±0.03 6.96±0.17
C. guilliermondii (1) 7.36±0.06 7.33±0.02 7.20±0.08 6.77±0.10
Non-Candida species T. mucoides (1) 7.44±0.08 7.31±0.01 7.10±0.04 6.59±0.03
K. ohmeri(1) 7.36±0.10 7.26±0.03 7.18±0.09 6.52±0.05
Fig. 1 Mean CFU/ml (log) and standard deviations for the strains of
C. albicans exposed to different experimental treatments: PBS as
control (P-L-); photosensitizer (P+L-); laser and PBS (P-L+); and laser
and photosensitizer (P+L+). Different letters (A, B, and C) represent
statistically significant differences among the groups (Tukey test,
p<0.05)
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albicans Candida species, and non-Candida species. The
susceptibility of the yeasts C. albicans and C. tropicalis to
laser light has already been described in the literature, and it
has been proposed that these yeasts may have endogenous
photosensitizers that enable them to initiate a photodynamic
reaction and subsequent cell death after exposure to radiation
[36, 37].
In all species studied, CFU/ml values were reduced by
photodynamic inactivation (P+L+) compared to the control
group (P-L-), but the microbial reduction levels were different
for the fungal species ranging from 0.33 to 0.85 log. From a
microbiological point of view, a minimum of 3 log steps must
be achieved to state antimicrobial effect [38]. Although the
reductions obtained in this study have been less than 1 log,
statistically significant differences between P+L+ and P-L-
groups were observed. In addition, this reduction was
achieved against biofilm growing pathogens, suggesting that
PDI with cationic nanoemulsion of zinc-phthalocyanine can
be a promising alternative for the dental clinic in the future.
Among Candida spp., the species most resistant to pho-
todynamic inactivation were C. albicans, C. glabrata, C.
norvegensis, C. krusei, and C. lusitaniae (reduction < 0.5
log). The features of biofilms formed by C. albicans, C.
glabrata, and C. krusei have been previously described [34,
35, 39, 40]. The biofilms formed by C. albicans are charac-
terized by a thickly structured, spatially organized complex
biofilm comprising a multitude of blastoconidia, pseudohy-
phae, and hyphae partially embedded in extracellular matrix
[39]. C. albicans biofilms have profound resistance to many
antifungal agents, such as fluconazole, amphotericin B,
nystatin, and chlorhexidine [39, 41]. The biofilm formed
by C. glabrata is thin, patchy, and rather compact, and
consists exclusively of blastoconidia embedded within an
EPS [40]. C. krusei form a thick multi-layer biofilm envel-
oped by voluminous extracellular material [34]. These last
two species are known to be resistant to fluconazole and are
extremely resistant to this antifungal agent when organized
in a biofilm [39]. The non-Candida albicans C. lusitaniae,
and C. norvegensis species have showed reduced suscepti-
bility to antifungals and cause rare infection in human
beings [5, 42]. All these characteristics could contribute to
a lower susceptibility to photodynamic inactivation because
the organization in biofilm seems to explain the phenotype
of resistance to the treatments [43].
The other non-albicans Candida species, likeC. tropicalis,
C. dubliniensis, C. parapsilosis, and C. guilliermondii,
showed greater susceptibility to photodynamic inactivation
(reduction > 0.5 log) than the other species described above.
Souza et al. [36] observed the greater susceptibility to PDI
mediated by methylene blue (312.6 μM) and diode laser
InGaAlP (28 J cm–2) for planktonic cultures of reference
strains of C. tropicalis, C. dubliniensis, and C. albicans than
C. krusei. The authors highlighted the difference in the sus-
ceptibility to PDI among different species, which must be
further investigated.
Fig. 2 Mean CFU/ml (log) and standard deviations for the strains of
non-albicans Candida species exposed to different experimental treat-
ments: PBS as control (P-L-); photosensitizer (P+L-); laser and PBS
(P-L+); and laser and photosensitizer (P+L+). Different letters (A, B
and C) represent significant statistically difference among the groups
(Tukey test, p<0.05)
Fig. 3 Mean CFU/ml (log) and standard deviations for the strains of
non-Candida species exposed to different experimental treatments:
PBS as control (P-L-); photosensitizer (P+L-); laser and PBS (P-L+);
and laser and photosensitizer (P+L+). Different letters (A, B, C, and D)
represent significant statistically difference among the groups (Tukey
test, p<0.05)
Fig. 4 Percentage of reduction, expressed as mean values (CFU/ml),
in the viability of C. albicans, non-albicans Candida species, and non-
Candida species exposed to photosensitizer (P+L-), laser light (P-L+)
or both laser and photosensitizer (P+L+) relative to the control group
(P-L-)
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Pereira et al. [44] evaluated the effect of PDI with meth-
ylene blue (312.6 μM) and an InGaAlP laser (350 J cm–2)
on biofilms formed by the reference strains C. albicans, S.
aureus, Streptococcus mutans, which were grown on acrylic
resin. PDI reduced 2.32 log10 of C. albicans biofilm and
1.00–1.90 log10 of C. albicans biofilm when associated with
bacterium. The structure analysis revealed that the groups
subjected to PDI exhibited less cellular aggregates. These
data suggest that lethal photosensitization occurred mainly
in the outermost layers of biofilms, which probably hap-
pened due to the inability of the photosensitizer to diffuse
through these structures.
The emerging pathogen T. mucoides produces biofilms
similar to Candida and exhibits reduced susceptibility to
amphotericin B, which causes difficulties in the treatment
of diseases caused by this yeast [10, 14]. K. ohmeri is
another opportunistic pathogen that seldom causes disease
but has ability to colonize central venous catheters [15, 19,
45]. These yeasts, T. mucoides and K. ohmeri, were inacti-
vated by PDI with reduction of 0.85 log and 0.84 log,
respectively. Currently, there are not any studies that evaluate
the effects of PDI on T. mucoides and K. ohmeri; however,
because these species exhibit higher sensibility to PDI than
Candida spp., further studies are needed to investigate the
mechanisms of PDI-mediated cytotoxicity on non-Candida
yeasts.
The reduction of yeasts achieved by the methods employed
in this work was greater than the reduction obtained by
Dovigo et al. [23]. These authors evaluated PDI mediated by
Photogem® irradiation by a red light-emitting diode (LED) on
biofilms formed by fluconazole-resistant and reference strains
of C. albicans and C. glabrata with mean reduction of 0.24
and 0.16 log, respectively. The photosensitizer used in the
present work was a cationic nanostructure of zinc 2,9,16,23-
tetrakis(phenylthio)-29H,31H-phthalocyanine (ZnPc) irradia-
tion by a laser with photodynamic activity on biofilms formed
by Candida spp., T. mucoides, and K. ohmeri. The analysis of
the efficiency of cationic and anionic ZnPc irradiated by
argon-pumped dye laser system (60 J cm–2) on C. albicans
planktonic culture was carried out by Mantareva et al. [28].
The cationic ZnPc was more efficient than anionic ZnPc, with
total reduction of 106–108 cells/ml ofC. albicans compared to
a 1–2 log reduction of cells, respectively, which is due to the
fact that cationic phthalocyanines exhibit better adhesion to
the cellular membrane [29].
RLP068/Cl, a tetracationic Zn(II) phthalocyanine chloride,
has been evaluated for cytotoxicity on antimicrobial-resistant
and susceptible strains of C. albicans, S. aureus, and Pseudo-
monas aeruginosa to determine whether these strains develop
resistance upon repeated exposure to the photosensitizer after
PDI irradiated by noncoherent halogen lamp (30 J cm–2) and
the photosensitizer in the dark. This experiment demonstrated
that 20 consecutive PDI treatments with RLP068/Cl did not
result in any resistant mutants and that, in dark conditions, the
minimum inhibitory concentration (MIC) of RLP068/Cl in-
creased only for S. aureus strains. However, even in this case,
the susceptibility of the susceptibility of these newly resistant
bacteria to PDI was not affected by the increase in the MIC of
RLP068/Cl [22]. This work showed that PDI exhibits a low
propensity for inducing resistance in the three prevalent hu-
man pathogens tested, and it can be used to treat localized
infections, such as oral and mucosal candidiasis, periodontitis,
or chronic wounds of various types and origins.
Mantareva et al. [29] evaluated the photodynamic effect of
two phthalocyanines, hydroxygallium(III) 2,9,16,23-tetrakis-
[3-(N-methyl)pyridyloxy]-phthalocyanine tetraiodide (GaPc1)
and hydroxygallium(III) 2,3,9,10,16,17,23,24-octakis-(3-pyri-
dyloxy)-phthalocyanine (GaPc2), with LED (50 J cm–2) in
comparison to methylene blue and a water-soluble tetra-
methylpyridyloxy-substituted Zn(II)- phthalocyanine
(ZnPcMe) on C. albicans biofilms grown on polymethylme-
thacrylate resin. Complete photodynamic inactivation of bio-
films with GaPc2 and ZnPcMewas found. The susceptibility of
C. albicans biofilms to PDI with GaPc2 and ZnPcMe suggests
a potential value of the both complexes for treatment of
denture-associated infections.
Longo et al. [27] developed a clinical protocol involving
PDI application mediated by aluminum-chloride-
phthalocyanine entrapped in cationic liposomes against car-
iogenic bacterials. In addition, the authors evaluated the
cytotoxicity of the proposed PDI protocol in eukaryotic
cells. The murine fibroblast cell line and human dental pulp
cell culture were used in this study. The same PDI protocol
applied against bacterials did not induce significant cytotox-
icity against the two eukaryotic cell lines evaluated. These
results show the tolerance of these eukaryotic cells to the
treatment with the PDI antimicrobial for oral infections.
In summary, photodynamic inactivation using cationic
nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-29H,
31H-phthalocyanine (ZnPc) in conjunction with a laser re-
duced the number of cells in the biofilms formed by strains
of C. albicans and non-Candida albicans as well the emerg-
ing pathogens T. mucoides and K. ohmeri.
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